Erythromycin And Benzoyl Peroxide
Drug - Erythromycin And Benzoyl Peroxide
The trade name of the product as shown on the labeling.
Dosage -
GEL; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Benzoyl Peroxide; Erythromycin
Multiple ingredients are in alphabetical order.
Strength -
5%;3%
The potency of the active ingredient(s), Benzoyl Peroxide; Erythromycin. May repeat for multiple part products.
Applicant -
QLT USA
The firm name holding legal responsibility for Erythromycin And Benzoyl Peroxide. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
065112
The FDA assigned number to Erythromycin And Benzoyl Peroxide. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Erythromycin And Benzoyl Peroxide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Mar 29, 2004
The date Erythromycin And Benzoyl Peroxide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Erythromycin And Benzoyl Peroxide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Erythromycin And Benzoyl Peroxide is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Qlt Usa Inc
The full name of the firm holding legal responsibility for the new application of Erythromycin And Benzoyl Peroxide.
Erythromycin And Benzoyl Peroxide
|
